drugset / Trial / NCT00006268
Immunotoxin Therapy in Treating Patients With Malignant Glioma
Phase 1/2
Completed
New Approaches to Brain Tumor Therapy Consortium
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Immunotoxins can locate tumor cells and kill them without harming normal cells. This may be an effective treatment for malignant glioma. PURPOSE: Phase I/II trial to study the effectiveness of immunotoxin therapy in treating patients who have malignant glioma.
Timeline
- Start
- 2000-10
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | cintredekin besudotox | Protein / enzyme biologic | — | Other |